Background: Breast cancer (BC) accounts for one of the most prevalent malignancies in the world. Inflammatory molecules modulate tumor microenvironment in BC that promotes tumor growth and metastasis. NF-κB (a transcription factor) that regulates multiple immune functions and acts as a crucial mediator of inflammatory responses.
Objective: The present study is aimed to quantitatively summarize the relation of NFKB1-94 ATTG (I, insertion/D, deletion) variant and risk of BC.
Methods: Further, the meta-analysis includes three independent case-control investigations that focus on NFKB1-94, ATTG I/D polymorphism, and BC patients. Web of Science, PubMed and Embase databases were used to retrieve relevant data. OR and 95% confidence interval of pooled studies were analyzed by using the MetaGenyo web tool.
Results: This study revealed a high heterogeneity. In all three genetic comparison models, the NFKB1-94 ATTG I/D variant is not related to the risk of BC. Further, no publication bias on the connection between NFKB1-94 ATTG I/D variant and risk of BC was observed.
Conclusion: To summarize, our meta-analysis demonstrates that the NFKB1-94 ATTG I/D polymorphism is not a major risk factor for BC.
[http://dx.doi.org/10.1186/s41182-017-0059-4] [PMID: 28794686]
[http://dx.doi.org/10.1016/j.neo.2018.05.002] [PMID: 29859426]
[http://dx.doi.org/10.1111/jicd.12369] [PMID: 30375186]
[http://dx.doi.org/10.1093/hmg/ddh008] [PMID: 14613970]
[http://dx.doi.org/10.1089/gtmb.2014.0271] [PMID: 25692306]
[http://dx.doi.org/10.31557/APJCP.2019.20.8.2493] [PMID: 31450925]
[http://dx.doi.org/10.1186/s12885-015-1652-8] [PMID: 26424146]
[http://dx.doi.org/10.2174/0929867321666141106124315] [PMID: 25386819]
[http://dx.doi.org/10.1038/srep31804] [PMID: 27545642]
[http://dx.doi.org/10.1007/s13193-013-0234-y] [PMID: 24426730]
[http://dx.doi.org/10.1007/s10549-013-2445-x] [PMID: 23529385]